CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02684734
NCT02684734N/ACompleted

Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis

University of British Columbia·observational·Posted Feb 18, 2016·Updated May 20, 2022

In Brief

An observational study for Ulcerative Colitis and Cytomegalovirus Infections. Completed, enrolled 50 participants across 1 site.

Detailed Summary

Colitis from reactivation of established cytomegalovirus (CMV) colonization can complicate the clinical course in patients with an acute flare of ulcerative colitis (UC). Accurate and timely detection of active CMV infection or disease with appropriate anti-viral therapy may reduce complications associated with acute UC flare. Limited information is available on the presence of colonic CMV infection in patients with quiescent ulcerative colitis. Prospective studies on factors associated with reactivation of CMV infection during active UC flare and its impact on disease progression are lacking. The hypothesis of this study are as follows: 1) CMV infection is prevalent in patients with ulcerative colitis irrespective of disease severity; 2) The degree of immunosuppression directly impacts CMV infection status in patients with ulcerative colitis

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 18, 2016
Enrollment StartDec 1, 2015
Primary CompletionNov 30, 2019
Study CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 10.4 years ago